CryoLife buys US company Ascyrus Medical for $200m | 合法醫療器材資訊網

2020年9月3日—BasedinFlorida,thecompanyhasdevelopedAscyrusMedicalDissectionStent(​AMDS),whichissaidtobetheworld'sfirstaorticarch ...

Ascyrus Medical Dissection Stent is said to be the world’s first aortic arch remodeling device to treat acute type A aortic dissections

CryoLife has acquired US company Ascyrus Medical. (Credit: Adam Radosavljevic from Pixabay)

Cardiac and vascular surgery company CryoLife has acquired US-based Ascyrus Medical in a deal valued at around $200m.

Based in Florida, the company has developed Ascyrus Medical Dissection Stent (AMDS), which is said to be the world’s first aortic arch remodeling device to treat acute type A aortic dissections.

The design of the AMDS will enable to quickly deploy graft in the aortic arch during a standard replacement of the ascending aorta, helping to add less than five minutes to the procedure time.

Ascyrus secured CE mark approval to market the AMDS in Europe, as well as H...